The US House approved a $32.8 billion financing measure, 339-85, on Wednesday that requires the coverage of abortifacient contraceptives but would continue existing law that forbids federal employees’ health insurance from covering abortion.

The New York Times reports that a much-anticipated registry of human embryonic stem cells that could be used for federally financed research should be available to scientists and the public within a week.